share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4：持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  06/18 09:45
牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on June 14, 2024. The specific details of the transaction, including the number of shares involved and the transaction price, were not disclosed in the announcement. As the head of the pharmaceutical giant, Bourla's financial moves are closely watched by investors for indications of his confidence in the company's performance and prospects. The absence of detailed transaction data in the report leaves the impact of this event on Pfizer's stock somewhat unclear to shareholders and potential investors.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction on June 14, 2024. The specific details of the transaction, including the number of shares involved and the transaction price, were not disclosed in the announcement. As the head of the pharmaceutical giant, Bourla's financial moves are closely watched by investors for indications of his confidence in the company's performance and prospects. The absence of detailed transaction data in the report leaves the impact of this event on Pfizer's stock somewhat unclear to shareholders and potential investors.
2024年6月14日，輝瑞公司（PFE）董事長兼CEO阿爾伯特·布爾拉進行了一筆交易。具體交易細節，包括涉及的股票數量和交易價格，在公告中沒有透露。作爲製藥巨頭的領導者，布爾拉的財務動向受到投資者關注，以了解他對公司業績和前景的信懇智能。報告中缺少詳細交易數據，使得這一事件對輝瑞公司的股東和潛在投資者的影響有些不明確。
2024年6月14日，輝瑞公司（PFE）董事長兼CEO阿爾伯特·布爾拉進行了一筆交易。具體交易細節，包括涉及的股票數量和交易價格，在公告中沒有透露。作爲製藥巨頭的領導者，布爾拉的財務動向受到投資者關注，以了解他對公司業績和前景的信懇智能。報告中缺少詳細交易數據，使得這一事件對輝瑞公司的股東和潛在投資者的影響有些不明確。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。